Select your country or region
- Africa
- America
- Asia
- Europe
- Oceania
- Angola
- Cape Verde
- Egypt
- Guinea-Bissau
- Mozambique
- São Tomé and Príncipe
- Australia
- New Zealand
- Bahrain
- Bangladesh
- Brunei
- Cambodia
- China
- Dubai (United Arab Emirates)
- Hong Kong SAR
- India
- Indonesia
- Iraq
- Japan
- Jordan
- Kuwait
- Laos
- Lebanon
- Malaysia
- Oman
- Pakistan
- Philippines
- Qatar
- Saudi Arabia
- Singapore (Asia Pacific)
- South Korea
- Sri Lanka
- Taiwan, China
- Thailand
- Vietnam
- Yemen
- Andorra
- Austria
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Gibraltar
- Iceland
- Ireland
- Italy
- Norway
- Poland
- Portugal
- San Marino
- Slovak Republic
- Spain
- Spain (Headquarters)
- Sweden
- Switzerland
- United Kingdom
- Vaticano
- Argentina
- Aruba
- Bolivia
- Brazil
- Canada
- Chile
- Colombia
- Costa Rica
- Curacao
- Dominican Republic
- Ecuador
- El Salvador
- Guatemala
- Honduras
- Mexico
- Nicaragua
- Panama
- Paraguay
- Peru
- Surinam
- Trinidad and Tobago
- United States
- Uruguay
- Venezuela
Grifols Australia PTY Ltd
Grifols Australia was established in 1990. Based in Melbourne, we cover the Australian and New Zealand markets. Our state-of-the art of Blood Typing reagents manufacturing facility is also based in our site in Melbourne.
We offer a comprehensive portfolio of Grifols products and. Safety and quality are our top priorities as we deliver on our mission to improve the health and well-being of people around the world.
Grifols Australia
Unit 5 / 80 Fairbank Road
Clayton South
Victoria 3169
AUSTRALIA
Contact information:
Tel: +61 3 95359333
Fax: +61 3 95359300
Mail:
australia_info@grifols.com
australia_medinfo@grifols.com
Notification of adverse reactions
To report an adverse drug reaction click here
Contact with Grifols
Certificate and ISO policy
Grifols Australia Pty Ltd is a member of the Grifols global family of companies, founded in 1909 by Josep Antoni Grifols i Lucas. Grifols is a leader in plasma collection and a leading provider of plasma-derived medicines and other innovative biopharmaceuticals. Grifols Australia offers a comprehensive range of transfusion medicine, immunoassay and pharmacy validation solutions for clinical laboratories, blood banks and hospitals. Grifols Australia maintains ISO 9001:2008 certification and is licensed by the Therapeutic Goods Administration to develop, manufacture, and distribute in-vitro diagnostic products. Grifols Australia is committed to quality, safety, and innovation to meet the demands of patient safety as well as represent the pioneering spirit of the global organization.